Neuroendocrine (NE) differentiation is a hallmark of advanced, androgen-independent prostate cancer, for which there is no successful therapy. NE tumor cells are nonproliferating and escape apoptotic cell death; therefore, an understanding of the apoptotic status of the NE phenotype is imperative for the development of new therapies for prostate cancer. Here, we report for the first time on alterations in intracellular Ca 2 þ homeostasis, which is a key factor in apoptosis, caused by NE differentiation of androgen-dependent prostate cancer epithelial cells. NEdifferentiating regimens, either cAMP elevation or androgen deprivation, resulted in a reduced endoplasmic reticulum Ca 2 þ -store content due to both SERCA 2b Ca 2 þ ATPase and luminal Ca 2 þ binding/storage chaperone calreticulin underexpression, and to a downregulated store-operated Ca 2 þ current. NE-differentiated cells showed enhanced resistance to thapsigargin-and TNF-a-induced apoptosis, unrelated to antiapoptotic Bcl-2 protein overexpression. Our results suggest that targeting the key players determining Ca 2 þ homeostasis in an attempt to enhance the proapoptotic potential of malignant cells may prove to be a useful strategy in the treatment of advanced prostate cancer.
Introduction
Neuroendocrine differentiation (NE) has been demonstrated in a variety of carcinomas arising in various tissues. Prostatic carcinoma, non-small-cell lung cancer, breast cancer, gastric carcinoma, and colorectal carcinoma are some of the tumors in which neuroendocrine differentiation has been described and suggested as an indicator of poor prognosis. However, the molecular and cellular mechanisms controlling NE differentiation are only partially understood.
Prostate cancer, one of the leading threats to men's health, is dependent on the androgens in the early stages. Consequently, androgen ablation therapies may, at this time, cause a tumor to regress. Nevertheless, these treatments do not prevent evolution to an androgen-independent stage, for which there is currently no successful therapy. 1 Therefore, an understanding of what drives the progression to androgen independence is critical. It is well established that androgenindependence is associated with tumor enrichment in cell phenotypes, for which apoptosis inhibition rather than enhanced proliferation is the main feature. 2, 3 Malignant neuroendocrine (NE) cells represent one of such phenotypes. 4 NE cells are fully differentiated cells that share structural, functional and metabolic properties with neurons. 5 They are a normal component of both the developing and the mature prostate epithelium, [4] [5] [6] although their origin and functional role is as yet, poorly elucidated. According to the existing hypotheses, NE cells are either derived from undifferentiated basal cells of the prostatic epithelium, 7 or have a neurogenic origin. 8 It is suggested that by releasing a variety of neurosecretory products, such as parathyroid hormone related peptides, neurotensin, serotonin, calcitonin and bombesin-related peptides, [4] [5] [6] these cells participate in the regulation of normal development and secretory activity of the prostate in the endocrine/paracrine fashion.
NE cells lack nuclear androgen receptors 9,10 and thus represent an androgen insensitive cell phenotype in the prostate. Expanding their population beyond normal proportions as a result of malignant transformation of epithelial/basal cells developing dormant NE features, is a common characteristic of prostate cancer progression. 4 Tumor enrichment in NE cells and the consequent increase in neurosecretory products with growth-promoting properties, contribute to increases in malignancy and reduce responsiveness to androgen ablation therapy.
The mechanisms of NE cells' apoptotis-resistance are still obscure, although existing evidence suggests that they are not associated with the common anti-apoptotic oncoprotein Bcl-2, 12 but are rather triggered by recently discovered survival proteins, such as survivin 13 and clusterin. 14 It is obvious that further studies of all aspects of NE cells' apoptotis-resistance are imperative for the development of new therapeutic options in the treatment of advanced prostate cancer.
In a recent study 15 we demonstrated that the apoptosisresistance of androgen-dependent LNCaP (Lymph Node Carcinoma of the Prostate 16 ) prostate cancer epithelial cells, associated with Bcl-2 overexpression, results in a complex rearrangement of the whole intracellular Ca 2 þ homeostasis. The characteristics of this rearrangement are reduced filling of the endoplasmic reticulum (ER) Ca 2 þ store, a decreased expression of key ER Ca 2 þ handling proteins and a substantial down-regulation of store-operated Ca 2 þ current (I SOC ). Bcl-2 overexpression is known to transform androgendependent LNCaP cells into an androgen-independent phenotype. 2 Since LNCaP cells can be differentiated into NE cells [17] [18] [19] -which are qualitatively different from the Bcl-2-mediated mechanisms of apoptosis-resistance and androgen independence and as it is also known that Ca 2 þ signaling plays a key role in proliferation and apoptosis, 20, 21 we therefore sought in the present study, to examine the type and manner of NE differentiation-induced alterations in Ca 2 þ homeostasis. Our results show for the first time that NE differentiation of prostate cancer epithelial cells causes significant modifications in Ca 2 þ homeostasis, which in their major hallmark features (i.e. the reduced filling of the ER Ca 2 þ store, the decreased expression of both endolemmal SERCA 2b Ca 2 þ ATPase and the luminal Ca 2 þ binding/storage chaperone calreticulin, as well as a substantial I SOC down-regulation) mimicked those associated with Bcl-2 overexpression. This would suggest the existence of common sites for Ca 2 þ -dependent triggering of various anti-apoptotic pathways in androgen-independent prostate cancer. We also show that NE-differentiated LNCaP cells become resistant to thapsigargin-(TG) and TNF-a-induced apoptosis.
Results
LNCaP cells rapidly acquire NE characteristics including the cessation of mitotic activity, the development of neuritic processes and an increased expression of neuron-specific enolase (NSE), under either pharmacological stimulation increasing intracellular cAMP levels, or under physiological stimulations using interleukins or long-term androgen deprivation. [17] [18] [19] 22 In a previous work 23 we presented evidence of LNCaP cells' NE differentiation in response to interventions that increase intracellular cAMP ([cAMP] in ) levels. In the present study, we have used both [cAMP] in elevation and long-term androgen deprivation by means of charcoal stripped culture medium, in order to induce NE differentiation of LNCaP cells. The functional results obtained on NEdifferentiated LNCaP cells were compared with regular androgen-dependent LNCaP cells, which served as a control.
Neuroendocrine differentiation decreases both ER free Ca 2 þ concentration and store-operated calcium entry
In terms of basic morphological NE characteristics, the two NE-differentiated cell types were similar to those described previously. 23 Culturing LNCaP cells for 4 days with a cAMP permeant analog (dibutyryl cAMP, Bt2cAMP 1 mM) plus a phosphodiesterase inhibitor (isobutylmethylxanthine, IBMX 100 mM) or with an androgen-deprived culture medium, induced NE differentiation. In order to comprehend the possible alterations in overall Ca 2 þ homeostasis induced by NE differentiation of LNCaP cells, we used a widely used experimental protocol, which allows the dissection of intra- 2 þ uptake mechanisms, of the mitochondrial type in particular, which may undergo upregulation during NE differentiation. In order to obtain more direct evidence on the filling status of ER Ca 2 þ store, we performed two additional series of experiments. In the first, we used cell exposure to ionomycin (IM, 1 mM) -a Ca 2 þ ionophore that causes complete ER Ca 2 þ store depletion when incorporated into membranes. 24 This was carried out in nominally Ca 2 þ -free extracellular saline, supplemented with the mitochondrial inhibitors, oligomycin (40 mM) and rotenon (20 mM), 15 15 The summaries of the experiments on the effects of NE differentiation on ER Ca 2 þ store content are presented in 
NE differentiation reduces a store-operated current
To determine whether or not the reduction in SOCE following NE differentiation, detected in fluorometric experiments, is indeed associated with a decrease in the store-operated membrane Ca 2 þ current (I SOC ), we proceeded to record the whole cell-patch clamp of this current both in the control and in the NE-differentiated LNCaP cells. In this series of experiments, we dialyzed cells with a high concentration of BAPTA, a highly potent Ca 2 þ chelator, which rapidly binds Ca 2 þ passively leaking from the ER, thereby causing its depletion, thereby activating I SOC . 25 Figure 3a shows that progression of the dialysis with 10 mM BAPTA containing intracellular solution, caused the development of inward I SOC in all three LNCaP cell types: control and NE-differentiated both by means of [cAMP] in elevation or androgen deprivation. The development of these currents followed comparable time courses, but the maximal densities, reached in about 4 min following the establishment of a wholecell configuration, were different (Figure 3a) . The I-Vs of fully developed currents in all cell types showed a strong inward rectification and reversal potential at around þ 40 mV, which is typical of I SOC (Figure 3b ). The quantification of maximal current density at 100 mV and 10 mM Ca 2 þ as a charge carrier, showed that it is the largest of the control LNCaP cells (1.470.2 pA/pF, n ¼ 12), which however decreases to 0.870.1 pA/pF and 0.670.1 pA/pF (n ¼ 8-9) following 96 h Figure 3c ). 24 h of differentiation were insufficient to reveal statistically significant differences in current densities.
Thus, the data on direct I SOC recordings indicate that the reduction in SOCE observed in NE-differentiated LNCaP cells by fluorometric means, is associated with a decrease in the density of store-operated current.
NE differentiation decreases SERCA 2b and calreticulin expression
One of the mechanisms by which NE differentiation may decrease the Ca 2 þ filling status of the ER, is by affecting the expression of ER-specific Ca 2 þ -handling proteins, such as the endolemmal SERCA pump and/or the luminal Ca 2 þ binding/storage chaperone, calreticulin. We therefore compared the expression of these proteins in both control and NEdifferentiated cells, using a semi-quantitative Western blot analysis. We analyzed the expression pattern of three other proteins, NSE, Bcl-2 and Bcl-xl. NSE, a neuroendocrine marker, is important in the appreciation of NE differentiation, whereas the assessment of common anti-apoptotic oncoproteins Bcl-2 and Bcl-xl, may provide a clue about the mechanisms of NE cells' apoptotis-resistance. Figure 4a shows that androgen deprivation as well as the [cAMP] cAMP] in elevation resulted in a notable decrease in Bcl-2 levels (to 0.65 and 0.49 of the control value respectively) and in the Bcl-xl level (to 0.8 and 0.6, Figure 4b ), suggesting that an anti-apoptotic oncoproteinindependent mechanism contributes to NE cells' apoptotisresistance.
Androgen deprivation confers resistance to thapsigargin and TNF-a-induced apoptosis
Possible alterations in the NE-differentiated LNCaP cells' potential to resist pro-apoptotic stimuli were assessed using TG, which has previously been shown to be an effective experiment inducer apoptosis in LNCaP cells, through an ER depletion mechanism, 26 as well as by using a physiological pro-apoptotic factor, namely TNF-a, acting via a surface membrane death receptor. 27 These experiments were conducted on NE-differentiated LNCaP cells by androgen deprivation, as this regimen is more physiological and more relevant from a clinical perspective. Figure 5a shows that, in control LNCaP cells, treatment with TG for 48 h induced apoptosis in a dose dependent manner, with a maximal percentage of apoptotic cells observed for 1 mM TG (2672.1%). Following NE differentiation, the fraction of apoptotic cells was reduced approximately 2-fold both in the absence of TG, as well as for each TG dose (Figure 5a ), thereby suggesting enhanced apoptotis resistance. The treatment of NE differentiated cells with TG for 72 h did not increase the fraction of apoptotic cells (data not shown), consequently suggesting that the apoptosis in differentiated cells was not delayed.
Qualitatively similar results were obtained with TNF-a (10 ng). This pro-apoptotic factor increased control LNCaP cells' apoptosis nearly 10-fold (from 0.570.1 to 5.171.4%), but appeared to be completely ineffective in inducing apoptosis of NE-differentiated LNCaP cells (Figure 5b ). The typical apoptotic features induced by treatment with TG or TNF-a are shown in Figure 5c . Apoptosis resistance was also detected by the TUNEL technique (Figure 6a ), thus demonstrating the decrease in LNCaP differentiated cells' apoptosis. 
Discussion
In the present study, we report two major findings characterizing NE differentiation in prostate cancer. Firstly, we describe the effect on Ca 2 þ homeostasis manifested through reduced filling of ER Ca 2 þ store, due to the under-expression of major Ca 2 þ -handling proteins, SERCA 2b and calreticulin and the downregulation of store-operated Ca 2 þ entry. Secondly, we demonstrate an enhanced resistance to apoptosis, which is not related to Bcl-2 and Bcl-xl, but, we believe, is a consequence of altered Ca 2 þ homeostasis.
Ca 2 þ homeostasis and apoptosis
The involvement of Ca 2 þ -dependent mechanisms in the induction and regulation of apoptosis is now generally accepted. Although interrelated, depending on the site of action, these mechanisms can be roughly subdivided into mitochondrial, cytoplasmic and ER-dependent types. Mitochondria may respond to high-matrix Ca 2 þ . This might be accumulated as a result of enhanced sequestration, either through a transition in permeability allowing the release of the following: Ca 2 þ , some matrix components as well as an apoptogenic factor, cytochrome c, or perhaps through an enhanced production of reactive oxygen species. 28 A rise in cytosolic free Ca 2 þ , which has long been considered as a primary death signal, leads to the activation of the calpain family of Ca 2 þ -dependent proteases participating in apoptosis, 29 and to the increase in the activity of some caspases.
30
Ca 2 þ homeostasis normally plays a pivotal role in the folding and processing of newly synthesized proteins as well as in maintaining the overall physiological state of the cell. When this decreases due to the depletion of ER Ca 2 þ stores, a stress response is activated, leading to growth arrest and cell death. 31 It is therefore possible, that disrupting intracellular calcium homeostasis, by the alteration of the way in which proteins regulating calcium homeostasis are expressed and function, will affect the cell's sensitivity to apoptosis. For example, it was shown that the over-expression of the intraluminal ER protein, calreticulin, increased cell sensitivity to TG-and staurosporine-induced apoptosis and, conversely, that cells lacking calreticulin showed considerable resistance to drug-induced apoptosis. 32 Androgen ablation therapy in prostatic adenocarcinoma induces an involution of prostate tissue mainly through the enhancement of cellular apoptosis, 33 which necessarily involves a pro-apoptotic decrease in the ER Ca 2 þ filling status. A fraction of malignant cells withstanding such therapy would emerge as new populations of apoptotis-resistant cells, for which underfilled ER represents another natural level of functional equilibrium. The enrichment of the prostate with such cell phenotypes eventually causes virtually all tumors to relapse into an androgen-independent, more aggressively growing type.
Apoptotis resistance in prostate cancer following androgen ablation therapy may evolve through two major pathways: the overexpression of the antiapoptotic Bcl-2 protein 2 or Bcl-2-independent NE differentiation. 3 In a recent study, we characterized Ca 2 þ homeostasis in a model system of LNCaP prostate cancer epithelial cells transfected with Bcl-2, 15 and showed that the Bcl-2-conferred apoptotis resistance on these cells is associated with reduced ER Ca 2 þ content and the substantial downregulation of I SOC . We also showed that reduced ER filling was a consequence of enhanced leakage and the lower expression of the key ER Ca 2 þ -handling proteins SERCA 2b and calreticulin, whereas diminished I SOC most probably reflected an adaptive decrease in the number of functional channels to the long-term reduction in the ER Ca 2 þ content. The results of our present work show that alterations in Ca 2 þ homeostasis induced by the NE differentiation of LNCaP cells, which are schematically represented in Figure 7 , basically mimic those of Bcl-2-overexpressing LNCaP cells, in terms of such hallmark features as an underfilled ER Ca 2 þ store, lower levels of ER SERCA 2b and calreticulin, and reduced I SOC .
Mechanisms of NE cells apoptotis resistance
Apoptosis is an extremely rare event in prostate cancer cells with neuroendocrine features in primary, metastatic, and recurrent disease. 3 Recent studies suggest that the apoptotis resistance of NE cells may be related to overexpression of new survival proteins, survivin 13 and/or clusterin. 34, 14 The first of these is a member of the inhibitor of apoptosis (IAP) family with direct caspase-3 and caspase-7 inhibitory action, 35 whereas the second represents multifunctional glycoprotein, commonly involved in the transport of lipoproteins, the inhibition of complement-mediated cell lysis, and the modulation of cell-cell interactions. 36 The antiapoptotic mechanisms of the latter remain to be clarified. Survivin is highly expressed in various common human cancers, [37] [38] [39] but not in normal tissues, and clusterin expression is strongly enhanced in tissues undergoing apoptosis. 40 The fact that LNCaP cells undergo similar alterations in Ca 2 þ homeostasis, irrespective of whether their apoptotis resistance was enhanced by Bcl-2 overexpression or as a result of NE differentiation, suggests that these alterations create a generally favorable environment for the functioning of mechanisms counteracting apoptosis. These alterations are therefore a necessary prerequisite for the cell's ability to successfully withstand proapoptotic stimuli. Our previous work showed that NE differentiation of LNCaP cells is also characterized by a strong overexpression of voltage-gated T-type Ca 2 þ channels, 23 which seem to be involved in the formation of neuronal-like morphological features (i.e., neurite outgrowth). Whether or not these channels contribute to the enhanced antiapoptotic potential of NE cells is not yet clear.
Implications for androgen-independent prostate cancer
Apoptosis is essential in maintaining tissue homeostasis. The acquisition of a resistance to apoptosis plays a pivotal role in tumor genesis by disrupting the balance between cell proliferation and cell destruction, and also by allowing cancer cells to escape radiation and chemotherapy. Androgenindependent prostate cancer is characterized by tumor enrichment in apoptosis-resistant cell phenotypes, which, although differing in specific antiapoptotic mechanisms, nevertheless shares the same basic changes in intracellular Ca 2 þ homeostasis. It would therefore seem that targeting the key players involved in its maintenance, in an attempt to enhance the proapoptotic potential of malignant cells, may prove to be a useful strategy in the treatment of advanced prostate cancer.
In the present work, we identify three molecular entities, the expression of which undergoes significant changes (reduction) during the NE differentiation of prostate cancer epithelial cells -calreticulin, SERCA 2b, and store-operated channel (SOC). The molecular origin of SOCs is still unknown, but there is strong evidence that the most likely candidate proteins belong to the transient receptor potential (TRP) channel family. [41] [42] [43] Thus, the identification of the specific TRPs involved in endogenous I SOC in prostate cancer cells acquires potentially great practical importance, as they may represent appropriate targets for influencing the apoptotic status of NE cells in advanced, androgen-independent prostate cancer.
Materials and Methods

Cell culture
The human prostatic carcinoma cell line LNCaP was obtained from the American Type Culture Collection (Rockville, MD, USA). Cells were grown in RPMI 1640 with 10% decomplemented fetal bovine serum (FBS, Deutcher, Brumath, France) at 371C, in a humidified atmosphere containing 5% CO 2 . The medium was supplemented with 300 mg/ml Lglutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin. Tissue culture media and supplements were obtained from Life Technologies (Cergy Pontoise, France). Cells were seeded in 75 cm 2 flasks and the growth medium was renewed every other day.
Prior to fluorescence measurements, the cells were removed from the culture flasks with 0.05% trypsin (Life Technologies, Cergy Pontoise, 
Charcoal-stripped medium
The tube containing charcoal 10% (w/v) and FBS was agitated for 16 h at 41C. Following 1 h's centrifugation at 10 000 g and 41C, the supernatant was collected and centrifuged again for 30 min at 27 000 g. The resultant supernatant was filtrated through 0.22 mm filters. Before use, the charcoalstripped FBS was decomplemented for 30 min at 561C. For both the cytoplasmic and the ER Ca 2 þ imaging, the detailed procedure has been described previously.
15,23
Electrophysiology and solutions
Membrane currents in LNCaP cells were recorded in the whole-cell configuration of the patch-clamp technique, using a computer-controlled EPC-9 amplifier (HEKA Electronic, Germany), as described previously. 44 Patch pipettes were made on a PIP-5 puller (HEKA Electronic, Germany) from borosilicate glass capillaries (WPI, USA). The resistance of the pipettes filled with the basic intracellular pipette solution (in mM): CsCl -120, MgCl 2 -3, BAPTA -10, HEPES -10, pH -7.3 (adjusted with Cs(OH)) varied between 4 and 6 MO.
The composition of the regular extracellular bath solution was (in mM): NaCl -120, KCl -5, CaCl 2 -2, MgCl 2 -2, glucose -5, HEPES -10, pH -7.3 (adjusted with Na(OH)). The high-Ca 2 þ , Na þ -free extracellular solution used for store-operated Ca 2 þ current recordings contained (in mM): TEA-Cl -120, CaCl 2 -10, glucose -5, HEPES -10, pH -7.3 (adjusted with TEA(OH)). External solutions were changed using a multibarrel puffing micropipette with common outflow, positioned in close proximity to the cell under investigation. During the experiment, the cell was continuously superfused with the solution via a puffing pipette to reduce possible artifacts related to the switch from static to moving solution and vice versa. Complete external solution exchange was achieved in less than 1 s.
Western blot analysis
Cells were lysed in an ice-cold buffer (pH 7.4) containing (in mM) 20 HEPES, 50 NaCl, 10 EDTA, 1 EGTA, 1 PMSF, 1% NP40, and a mixture of protease inhibitors. After 1 h on ice, the lysates were homogenized and centrifuged at 1500 rpm for 10 min at 41C. The resulting supernatants were stored at À801C until use. Samples were fractionated in a Laemmlitype SDS-PAGE (16%). The proteins were then transferred onto a nitrocellulose membrane using a semi-dry electroblotter (Bio-Rad). After transfer, the membrane was cut into thin strips that were further processed for immunodetection. The strips were blocked in TNT (15 mM Tris buffer (pH 8), 140 mM NaCl, 0.05% Tween 20, 3% skimmed dry milk for 30 min at room temperature), washed in TNT three times, then incubated with mouse monoclonal antibodies for 1 h at room temperature. After three washes in TNT, the strips were treated with the corresponding horseradish 2 þ concentration which had been lowered through the downregulated expression of SERCA pump and CRT, and decreased store-operated Ca 2 þ entry, which was most probably associated with the diminished density of functional SOCs peroxidase-linked secondary antibodies (Zymed Laboratoires Inc., San Francisco, CA, USA), for 1 h. After washes in TNT without milk, the strips were processed for chemiluminescent detection using Supersignal West Pico chemiluminescent substrate (Pierce chemical Co., Rockford, IL, USA), according to the manufacturer's instructions. Blots were then exposed to X-Omat AR films (Eastman Kodak Co., Rochester, NY, USA). Blot intensity was quantified by scanning densitometry (Bio-Rad).
Determination of apoptosis
The Hoechst technique
The level of apoptosis was estimated from the number of apoptotic bodies visualized by Hoechst staining. The percentage of apoptotic cells was determined by counting at least 500 cells in random fields (the detailed procedure has been described previously. 26 The TUNEL technique Apoptosis was also detected by the terminal deoxynucleotide transferasemediated dUTP-biotin nick-end labellingterminal deoxynucleotide transferase-mediated dUTP-biotin nick-end labelling technique (TUNEL) using an apoptosis detection kit (Borhringer Mannheim).
DNA fragmentation analysis
Cells (2 Â 10 6 cells per sample) were lysed in an extraction buffer (50 mM Tris pH 7.5, 10 mM EDTA, 1% sodium dodecyl sulfate (SDS), and 200 mg/ ml proteinase K, 50 mg/ml RNase A) and incubated at 371C for 6 h. DNA was subsequently extracted with phenol/chloroform/isoamyl alcohol (25 : 24 : 1) and then precipitated with isopropyl alcohol, pelleted, and resuspended in TE with 20 mg/ml Rnase. The DNA was quantitated spectroscopically, and 10 mg of DNA was analyzed for fragmentation on a 1.5% agarose gel. The gel was stained with ethidium bromide and visualized using a UV light source.
Reagents and chemicals
All chemicals were from Sigma (l'Isle d'Abeau, France), except for fura-2/ AM and thapsigargin, which were purchased from France Biochem (Meudon, France).
Data analysis and statistics
Each experiment was repeated several times. The data were analyzed using PulseFit (HEKA Electrinics, Germany) and Origin 5.0 (Microcal Software Inc., Northampton, MA, USA). Results were expressed as mean7standard error of the mean (S.E.M.). Statistical analysis was performed using the Student's t-test and ANOVA tests, followed by Tukey-Kramer post-tests (Po0.05 considered significant).
